The Patent Finder

Pharmexa Inc.

Also on record
Records under this name other than the patents Pharmexa Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Pharmexa Inc.

PatentTitleStatus Expires Confidence
US 8,017,745Plasmodium falciparum antigens and methods of use
Formerly held
Term ended
Term ended Aug 30, 2026 · From the USPTO record
Term endedTerm ended Aug 30, 2026From the USPTO record
US 8,741,576Heteroclitic analogs and related methods
Formerly held
Term ended
Term ended Jun 22, 2025 · From the USPTO record
Term endedTerm ended Jun 22, 2025From the USPTO record
US 9,511,134Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
Formerly held
Lapsed on the fee record
Ended Dec 6, 2024 · From the USPTO record
Lapsed on the fee recordEnded Dec 6, 2024From the USPTO record
US 7,572,882Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
Formerly held
Term ended
Term ended Nov 2, 2023 · From the USPTO record
Term endedTerm ended Nov 2, 2023From the USPTO record
US 7,026,443Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
Formerly held
Term ended
Term ended Mar 26, 2022 · From the USPTO record
Term endedTerm ended Mar 26, 2022From the USPTO record
US 7,462,354Method and system for optimizing minigenes and peptides encoded thereby
Formerly held
Term ended
Term ended Jan 26, 2021 · From the USPTO record
Term endedTerm ended Jan 26, 2021From the USPTO record
US 6,419,931Compositions and methods for eliciting CTL immunity
Formerly held
Term ended
Term ended Jul 16, 2019 · From the USPTO record
Term endedTerm ended Jul 16, 2019From the USPTO record
US 6,322,789HLA-restricted hepatitis B virus CTL epitopes
Formerly held
Term ended
Term ended Nov 27, 2018 · From the USPTO record
Term endedTerm ended Nov 27, 2018From the USPTO record
US 7,252,829HLA binding peptides and their uses
Formerly held
Term ended
Ended no later than Jun 17, 2018 · From the USPTO record
Term endedEnded no later than Jun 17, 2018From the USPTO record
US 6,534,482Expression vectors for stimulating an immune response and methods of using the same
Formerly held
Term ended
Term ended May 13, 2018 · From the USPTO record
Term endedTerm ended May 13, 2018From the USPTO record
10 of 24 patents shown.
Pro members see all 24.
Pro members: see all 24 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited